![Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI](https://ars.els-cdn.com/content/image/1-s2.0-S000287031730337X-gr1.jpg)
Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI
![From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5d40697d-4d20-47cd-b489-b6be7c5fc305/gr1_lrg.jpg)
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach - European Journal
![Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter](https://pbs.twimg.com/media/D5ORU8GU0AEQK_8.jpg)
Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter
![Role and Timing of Aspirin Therapy Following PCI in Patients With Atrial Fibrillation - American Journal of Cardiology Role and Timing of Aspirin Therapy Following PCI in Patients With Atrial Fibrillation - American Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/0943183e-f33a-4a12-a174-ff4738b722e4/gr1.jpg)
Role and Timing of Aspirin Therapy Following PCI in Patients With Atrial Fibrillation - American Journal of Cardiology
![Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence - European Journal of Internal Medicine Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence - European Journal of Internal Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3dfdb8f3-d10b-499d-8a26-27404b5030e8/gr4_lrg.jpg)
Antithrombotic treatment in patients with atrial fibrillation undergoing coronary angioplasty: rational convincement and supporting evidence - European Journal of Internal Medicine
![Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies - Atherosclerosis Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies - Atherosclerosis](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9777faa4-f7b3-418a-a24b-2fc335f3276c/gr1.jpg)
Atrial fibrillation with percutaneous coronary intervention: Navigating the minefield of antithrombotic therapies - Atherosclerosis
![The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com](https://s3.amazonaws.com/prod.tctmd.com/public/2017-11/CE78021B-FDD9-438F-9EBF-296EF9F7AE8E.png)
The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com
![Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - The American Journal of the Medical Sciences Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - The American Journal of the Medical Sciences](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/afc1eb4c-9882-4acd-b318-20ab013ee0d1/gr1.jpg)
Use and Outcomes of Triple Antithrombotic Therapy with Non-Vitamin K Antagonists in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - The American Journal of the Medical Sciences
![Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/de92b71a-c6ca-4a4d-a5be-6c20525f240c/gr1.jpg)
Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology
![The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com](https://s3.amazonaws.com/prod.tctmd.com/public/styles/large_slide_teaser/public/2016-11/4441280.png?itok=ZCy4xiWq)
The ENTRUST AF-PCI Trial: Edoxaban in Patients With Atrial Fibrillation and PCI - Design, Rationale, and Status | tctmd.com
![Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/37341bb4-e97f-43e5-9e52-520b2e6d2aba/gr2_lrg.jpg)
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - Journal of Cardiology
![Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f910ed62-9a6a-47a3-a724-dfecec92de4a/gr2_lrg.jpg)
Antithrombotic therapy in atrial fibrillation patients with coronary artery disease: shifting paradigm to a “less is more” concept regimen - Journal of Cardiology
![Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation ( ENTRUST-AF PCI): a randomised, open-label, phase 3b trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1a05d590-96b1-4169-b837-6095d4225c8b/gr1.gif)